Novartis shared today the difficult news that they are stopping the VIBRANT-HD study of Branaplam, after some participants devoloping side effects.

Even if this news can be disappointing, the HD Community will keep positive and hope the remaining trials and tests can bring some good news.

Categories: NewsResearch

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

en_USEnglish
Skip to content